New Food Invest
-
DATABASE (1659)
-
ARTICLES (741)
Challengers Capital was founded in 2014. Its founding partners are angel investors Xie Xianlin and Tang Binsen. It manages three RMB funds with around RMB 2 billion in management.Challengers Capital focuses on areas like consumption upgrade, entertainment, gaming, enterprise services and fintech.
Challengers Capital was founded in 2014. Its founding partners are angel investors Xie Xianlin and Tang Binsen. It manages three RMB funds with around RMB 2 billion in management.Challengers Capital focuses on areas like consumption upgrade, entertainment, gaming, enterprise services and fintech.
NAOS is a French multinational company operating in 100 countries, with a special focus on skincare. Bioderma is its best-known brand. Established over 40 years ago by pharmacist-biologist Jean-Noël Thorel, the company stresses the importance of ecobiology. The company recently extended its scope from skincare to a wider interest in the healthcare sector, such as beauty and well-being. Mediktor is its first investment in tech startups.
NAOS is a French multinational company operating in 100 countries, with a special focus on skincare. Bioderma is its best-known brand. Established over 40 years ago by pharmacist-biologist Jean-Noël Thorel, the company stresses the importance of ecobiology. The company recently extended its scope from skincare to a wider interest in the healthcare sector, such as beauty and well-being. Mediktor is its first investment in tech startups.
Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.
Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.
Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.
Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.
TPG-SV China Ventures is a joint investment venture established in September 2018 by SoftBank Ventures Korea and private equity group TPG. With a fund of $300m, the VC is managed by TPG’s China team in the TMT industry and seeks early-stage investment opportunities in internet, technology and media.
TPG-SV China Ventures is a joint investment venture established in September 2018 by SoftBank Ventures Korea and private equity group TPG. With a fund of $300m, the VC is managed by TPG’s China team in the TMT industry and seeks early-stage investment opportunities in internet, technology and media.
Chongqing Environmental Fund was established by China’s Ministry of Ecology and Environment and the Chongqing Municipal Government in June 2015. As of late December 2018, the fund has invested RMB 448m in 28 projects. It has launched 13 funds with a total capital of about RMB 8bn.
Chongqing Environmental Fund was established by China’s Ministry of Ecology and Environment and the Chongqing Municipal Government in June 2015. As of late December 2018, the fund has invested RMB 448m in 28 projects. It has launched 13 funds with a total capital of about RMB 8bn.
Gemboom Venture Capital was founded in Shenzhen in 2016 and mainly invests in early-stage startups from angel to Series A rounds. It specializes in high-tech, industrial upgrades and consumables. The VC invests primarily in big cities like Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou and Chengdu.
Gemboom Venture Capital was founded in Shenzhen in 2016 and mainly invests in early-stage startups from angel to Series A rounds. It specializes in high-tech, industrial upgrades and consumables. The VC invests primarily in big cities like Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou and Chengdu.
Singtel Innov8 is the venture arm of Singapore-based telecommunications company Singtel. It invests in companies that can potentially bolster Singtel's own capabilities in communications technologies, media services and customer experience. Innov8 has invested in companies at home and abroad, including in Indonesia, China, the USA and Israel. It has made exits through the sale of its portfolio companies (Viki and Tempo.AI) and via IPOs.
Singtel Innov8 is the venture arm of Singapore-based telecommunications company Singtel. It invests in companies that can potentially bolster Singtel's own capabilities in communications technologies, media services and customer experience. Innov8 has invested in companies at home and abroad, including in Indonesia, China, the USA and Israel. It has made exits through the sale of its portfolio companies (Viki and Tempo.AI) and via IPOs.
WuXi AppTec is a Chinese company that specializes in the outsourcing of R&D in the pharmaceuticals, biotechnology and medical devices sectors. Listed on the Hong Kong Stock Exchange, WuXi AppTec has invested in drug development and healthcare firms globally. Its portfolio includes Insilico Medicine, which is developing an AI platform for drug development, brain disease research firm Verge Genomics and Indonesian healthcare platform Halodoc.
WuXi AppTec is a Chinese company that specializes in the outsourcing of R&D in the pharmaceuticals, biotechnology and medical devices sectors. Listed on the Hong Kong Stock Exchange, WuXi AppTec has invested in drug development and healthcare firms globally. Its portfolio includes Insilico Medicine, which is developing an AI platform for drug development, brain disease research firm Verge Genomics and Indonesian healthcare platform Halodoc.
Founded in 2000 by Hans-Jurgen Schmitz and Mark Tluszcz, Mangrove Capital Partners is a Luxembourg-based fund. It has, as an early investor, backed four unicorns, namely, Skype, Wix, WalkMe and LetGo, as well as a multitude of other successful tech startups. It participates at all stages of investment and has made over 120 investments, including as lead investor in 40 of these. It has seen 15 exits to date, including Skype and, most recently, has invested in the Seed round of Attentive.us and in the Series B of K Health and Series A of Flo Health.
Founded in 2000 by Hans-Jurgen Schmitz and Mark Tluszcz, Mangrove Capital Partners is a Luxembourg-based fund. It has, as an early investor, backed four unicorns, namely, Skype, Wix, WalkMe and LetGo, as well as a multitude of other successful tech startups. It participates at all stages of investment and has made over 120 investments, including as lead investor in 40 of these. It has seen 15 exits to date, including Skype and, most recently, has invested in the Seed round of Attentive.us and in the Series B of K Health and Series A of Flo Health.
Eight Roads Ventures is the investment arm of Bermuda-based investment management giant Fidelity International Limited, which was founded in 1969. (It was formerly called Fidelity Growth Partners.) Its investment focus includes emerging technology and healthcare companies in North America, Europe and China in their go-to-market stage and early customer traction. It has offices in the UK, China, India and Japan and has seen 42 exits and has invested in over 300 companies to date. It also participates in Series A to D funding rounds and is a major investor in real estate.
Eight Roads Ventures is the investment arm of Bermuda-based investment management giant Fidelity International Limited, which was founded in 1969. (It was formerly called Fidelity Growth Partners.) Its investment focus includes emerging technology and healthcare companies in North America, Europe and China in their go-to-market stage and early customer traction. It has offices in the UK, China, India and Japan and has seen 42 exits and has invested in over 300 companies to date. It also participates in Series A to D funding rounds and is a major investor in real estate.
Banco Sabadell is one of the biggest and oldest banking groups in Spain. Based in Barcelona, it was established in 1881 and has an annual revenue exceeding US$9.8 billion. The bank caters to small and medium enterprises and serves 12 million customers. Banco Sabadell's subsidiary, BStartup, was founded in 2014 to support entrepreneurs through two investment vehicles: BSartup10, which targets startups during their set-up phase and offers highly customized services and Sabadell Venture Capital, which invests in startups seeking Series A or B funding. The bank currently has 50 offices focused on catering to the needs of startups.
Banco Sabadell is one of the biggest and oldest banking groups in Spain. Based in Barcelona, it was established in 1881 and has an annual revenue exceeding US$9.8 billion. The bank caters to small and medium enterprises and serves 12 million customers. Banco Sabadell's subsidiary, BStartup, was founded in 2014 to support entrepreneurs through two investment vehicles: BSartup10, which targets startups during their set-up phase and offers highly customized services and Sabadell Venture Capital, which invests in startups seeking Series A or B funding. The bank currently has 50 offices focused on catering to the needs of startups.
China Creation Ventures (CCV) was founded in 2017 by Wei Zhou, the former managing partner of KPCB China. Headquartered in Beijing, it invests mainly in early-stage startups in sectors such as finance and TMT. Series A funding accounts for around 70% of total investment. CCV manages USD and RMB funds collectively worth over RMB 3 billion.
China Creation Ventures (CCV) was founded in 2017 by Wei Zhou, the former managing partner of KPCB China. Headquartered in Beijing, it invests mainly in early-stage startups in sectors such as finance and TMT. Series A funding accounts for around 70% of total investment. CCV manages USD and RMB funds collectively worth over RMB 3 billion.
A Boston-based VC founded in 1984 with an impressive investment history, currently totaling US$9.5 billion. With offices in Boston, Menlo Park, California and London, Summit Partners has invested in more than 460 companies in technology, healthcare, life sciences and other high-growth industries, including as lead investor in 77 companies. It has seen 192 exits to date. Recent major investments include as lead investor in Red Points' Series C round and in Markforged's Series D round.The company also provides services, such as, recruitment of senior executives and board members and Peak Performance Groups to help companies’ identify and execute growth initiatives and operational efficiency.
A Boston-based VC founded in 1984 with an impressive investment history, currently totaling US$9.5 billion. With offices in Boston, Menlo Park, California and London, Summit Partners has invested in more than 460 companies in technology, healthcare, life sciences and other high-growth industries, including as lead investor in 77 companies. It has seen 192 exits to date. Recent major investments include as lead investor in Red Points' Series C round and in Markforged's Series D round.The company also provides services, such as, recruitment of senior executives and board members and Peak Performance Groups to help companies’ identify and execute growth initiatives and operational efficiency.
Founded in 2015, the Porto-based Betwixt Ventures is no longer active. The venture capital fund manager and advisory firm specialized in early-stage investments in Portuguese tech startups. It invested in startups vetted by other business angels, or co-invested with other VC partners and private investors. The focus of the investments was to fill in the funding gap between seed and Series A rounds.
Founded in 2015, the Porto-based Betwixt Ventures is no longer active. The venture capital fund manager and advisory firm specialized in early-stage investments in Portuguese tech startups. It invested in startups vetted by other business angels, or co-invested with other VC partners and private investors. The focus of the investments was to fill in the funding gap between seed and Series A rounds.
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
New Food Invest: Building a plant-based business in the US
With plant-based startups experiencing exponential growth but facing increasingly intense competition, experts consider the opportunities and barriers in the sector
OLIO: Zero food waste app expands with new product categories, going global
Recent $43m Series B funding will let sustainability app more than triple hiring, add homemade products and household goods to product listings
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
Future Food Asia: Temasek, Continental Grain on investing in agrifood in Singapore and China
The two heavyweight investors discuss opportunities, needs and how agrifood startups can scale in Asian markets
Bayer Growth Ventures' Paimun Amini: Invest in tech for smarter, more sustainable farming
Corporate venture capital showed up in abundance at Smart Agrifood Malaga, where CompassList spoke with Paimun Amini, Director of Venture Investments for Bayer Growth Ventures (BGV)
Future Food Asia 2021: Impact assessments – getting the metrics right
Common impact measures are useful but each situation requires specific, sometimes subjective considerations. The priority is to gauge if the impact has led to positive changes
Future Food Asia 2021: Regenerative agriculture in Asia
The unique challenges facing regenerative agriculture in Asia require solutions different from those in the West, presenting opportunities for microfinancing and impact investment
Shilling Capital Partners: Growing Portuguese tech businesses from seed
An early mover, the influential angel investing firm is accelerating local techs into Brazil and globally
AquaCultured Foods: World's first whole-cut vegan seafood made through microbial fermentation
Armed with its fermentation technology and proprietary strain of fungi, AquaCultured is closing an oversubscribed funding round, raising more than $1.5m to launch its non-GMO seafood alternatives, with plans to expand to more food verticals and overseas
SWITCH Singapore: Race in agrifood tech as a solution to feeding 10bn people
While the potential gains are huge, giving tech solutions to farmers, especially smallholders in developing countries, remains a work in progress
Les Nouveaux Affineurs: Disrupting centuries-old French cheese culture
Backed by Michelin-star chefs and investors, Les Noveaux Affineurs is gearing up to be a global player in the billion-dollar vegan cheese market
Sorry, we couldn’t find any matches for “New Food Invest”.
POPULAR DATABASE
